According to the International Trade Commission, a section 337 patent complaint on certain devices with secure communication capabilities, components thereof was filed on behalf of VirnetX, Inc. and Science Applications International Corporation (SAIC) on Sept. 10. The proposed respondent is Apple.
An administrative law judge found no violations of Section 337 by Apple in the International Trade Commission’s investigation of certain electronic devices, including wireless communication devices, portable music and data processing devices, and tablet computers (337-TA-794). The investigation was requested by Samsung. In the final initial determination dated Sept. 14, the ALJ found no infringement by Apple, and also said no domestic industry exists that practice the patents at issue.
The International Trade Administration published notices in the Sept. 17 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Commission is asking for comments by about Sept. 25 on a Sept. 10 patent complaint filed on behalf of South Alabama Medical Science Foundation, Merck & Cie, and Pamlab LLC, which alleges violations of Section 337 of the Tariff Act of 1930 in the import into the U.S., the sale for import, and the sale within the U.S. after import of certain reduced folate nutraceutical products and L-Methylfolate raw ingredients used therein (D/N 2912). The complaint names as respondents Gnosis SpA of Italy; Gnosis Bioresearch SA of Switzerland; Gnosis USA Inc. of Pa.; and Macoven Pharmaceuticals LLC of Texas. ITC is asking for comments on any public interest issues that might affect ITC consideration, including whether the issuance of an exclusion order and/or cease and desist order would impact the public interest.
The International Trade Administration published notices in the Sept. 14 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):
The International Trade Administration issued the preliminary results of its administrative review of the antidumping duty order on uncovered innerspring units from China (A-570-928) for one company, Tai Wa Hong. The ITA preliminarily determined that Tai Wa Hong failed to cooperate in the review, and so assigned it an adverse facts available (AFA) rate of 234.51 percent. According to the ITA's issues and decision memo in the IAACCESS database, Tai Wa Hong is a Macau company that failed to respond to the ITA's questionnaires. Because the company is not in China for the ITA's purposes, it assigned the company its own AFA rate rather than the China-wide rate. These preliminary results are not in effect. The ITA may modify them in the final results of this review and change the estimated AD cash deposit rate for this company.
The International Trade Commission is publishing notices in the Sept. 13 Federal Register on the following AD/CV injury, Section 337 patent, and other trade proceedings (any notices that warrant a more detailed summary will appear in another ITT article):
The International Trade Commission will review an administrative law judge’s finding of violations of Section 337 by LG in its patent investigation of certain light-emitting diodes and products containing same (337-TA-784). The case, instituted in July 2011, is based on two complaints filed by OSRAM. The ITC is asking for comments on certain aspects of the ALJ’s finding, as well as the issues of remedy, bonding, and the public interest, by Sept. 21.
According to the International Trade Commission, a section 337 patent complaint on certain reduced folate nutraceutical products and L-methylfolate raw ingredients used therein was filed on behalf of South Alabama Medical Science Foundation, Merck & Cie, and Pamlab LLC on Sept. 10. The proposed respondents are:
The International Trade Administration published notices in the Sept. 12 Federal Register on the following AD/CV proceedings (any notices that announce changes to AD/CV duty rates, scope, affected firms, or effective dates will be detailed in another ITT article):